SCHEMBL257273

SCHEMBL257273

Cc1ccc(C(=O)c2ccccc2)c(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.60
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
PKM P14618 1/20 0.58
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
AKR1C3 P42330 1/20 0.51
SRD5A2 P31213 1/20 0.51
POLB P06746 1/20 0.51
MAPK13 O15264 1/20 0.51
MAPK12 P53778 1/20 0.51
MAPK11 Q15759 1/20 0.51
MAPK14 Q16539 1/20 0.51
ALOX15 P16050 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAPT P10636 2/20 0.49
HTT P42858 2/20 0.49
MAPK1 P28482 1/20 0.49
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9422050 0.89 RAB9A (0.56) TP53NPC1RAB9APKMAKR1C3
SCHEMBL9422052 0.89 RAB9A (0.56) TP53NPC1RAB9APKMAKR1C3
SCHEMBL7271917 0.86 SRD5A2 (0.60) TP53NPC1RAB9AMEN1KMT2A
SCHEMBL95646 0.86 TP53 (0.57) TP53NPC1RAB9APKMMEN1
SCHEMBL23070442 0.85 HPGD (0.53) TP53NPC1RAB9APKMMEN1
SCHEMBL10774999 0.84 MAPT (0.50) TP53NPC1RAB9APKMKMT2A
SCHEMBL11363696 0.84 TP53 (0.50) TP53NPC1RAB9APKMMEN1
SCHEMBL7208739 0.84 RAB9A (0.59) NPC1RAB9APKMMEN1KMT2A
SCHEMBL28384878 0.83 AKR1C3 (0.61) TP53NPC1PKMMEN1KMT2A
SCHEMBL29826380 0.83 AKR1C3 (0.57) NPC1RAB9APKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109970976-A The polysilsesquioxane and its preparation method and application of tetraphenylethylene base bridging 苏州大学 2019-07-05 CN claimed
CN-115960483-A Method for reducing shrinkage stress of photocureable coating by using pH-responsive cationic microgel 江南大学 2023-04-14 CN disclosed
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed
EP-0480365-B1 Production of solder masked electric circuit boards NIPPON PAINT CO LTD (JP) 1996-01-10 EP disclosed
US-5181984-A PRODUCTION OF SOLDER MASKED ELECTRIC CIRCUIT BOARDS NIPPON PAINT CO., LTD. (JP) 1993-01-26 US disclosed
EP-0092628-B1 PROCESS FOR THE PREPARATION OF PHENYL KETONES STARTING FROM HALOGEN OR TRIHALOGEN METHYL BENZENES AND ALIPHATIC OR AROMATIC TRIHALOGEN-METHYL COMPOUNDS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-05-29 EP disclosed
US-4495311-A METAL CHELATES OR SALTS AND BENZOYL COMPOUNDS AS ADDIVES PRINCETON POLYMER LABORATORIES, INC. (US) 1985-01-22 US disclosed
US-4347383-A BY REACTING BENZOPHENONE-IMINE WITH OXYGEN OR BENZOPHENONE WITH OXYGEN AND AMMONIA MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1982-08-31 US disclosed
US-3981856-A BIODEGRADATION, ADDITION POLYMERS PRINCETON POLYMER LABORATORIES, INCORPORATED (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 TP53 4509/4885NPC1 1990/4885RAB9A 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.